MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Potrebbe interessarti anche
Chi ha guadagnato
Ultime notizie crypto
Le future riunioni della Fed rischiano di vedere aumentare i disaccordi Alimentare la volatilità del mercato
Tom Lee: Il rapporto rischio-ricompensa di BTC ed ETH diventa piuttosto attraente
Coinbase è ora online con Rayls (RLS) spot trading
Un certo indirizzo di balena ha depositato 10 milioni di U in HyperLiquid, dando inizio a una posizione long di 20x ETH.
Coinbase to List Rayls (RLS)
Assistenza clienti:@weikecs
Cooperazione aziendale:@weikecs
Trading quantitativo e MM:[email protected]
Servizi VIP:[email protected]